FDA — authorised 12 October 2017
- Application: BLA761049
- Marketing authorisation holder: EMD SERONO INC
- Indication: Labeling
- Status: approved
🇺🇸 Bavencio in United States
FDA authorised Bavencio on 12 October 2017
Marketing authorisation
Bavencio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Bavencio approved in United States?
Yes. FDA authorised it on 12 October 2017.
Who is the marketing authorisation holder for Bavencio in United States?
EMD SERONO INC holds the US marketing authorisation.